Purpose: To evaluate the effect of postoperative latanoprost administration on central macular thickness (CMT) after uneventful cataract surgery in glaucoma patients.
Setting: Farabi Eye Hospital, Tehran, Iran.
Design: Prospective randomized clinical trial.